Intellia Therapeutics Inc buy Chardan Capital
Start price
27.10.25
/
50%
€12.31
Target price
27.10.26
€41.25
Performance (%)
14.87%
Price
11:57
€14.14
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital currently has a performance of 14.87%. This prediction currently runs until 27.10.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 11.848% | 11.848% |
| iShares Core DAX® | 0,41 % | 8,82 % |
| iShares Nasdaq 100 | 3,68 % | 10,82 % |
| iShares Nikkei 225® | 2,70 % | 15,25 % |
| iShares S&P 500 | 2,44 % | 7,93 % |
Comments by Chardan_Capital for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) had its price target lowered by analysts at Chardan Capital from $60.00 to $48.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Chardan_Capital for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€11.72
27.02.26
27.02.26
€22.04
27.02.27
27.02.27
20.65%
11:57
11:57
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.60
09.05.25
09.05.25
€60.64
09.05.26
09.05.26
86.05%
11:57
11:57
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.69
28.02.25
28.02.25
€65.29
28.02.26
28.02.26
13.42%
01.03.26
01.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€13.46
18.11.24
18.11.24
€86.10
18.11.25
18.11.25
-46.48%
19.11.25
19.11.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€35.98
07.08.23
07.08.23
€97.28
07.08.24
07.08.24
-45.29%
08.08.24
08.08.24